| Dr Andrew Mark Doroschak, DDS, MS | |
|
625 E Nicollet Blvd, Suite 340, Burnsville, MN 55337-6734 | |
| (952) 435-0370 | |
| Not Available |
| Full Name | Dr Andrew Mark Doroschak |
|---|---|
| Gender | Male |
| Speciality | Dentist - Endodontics |
| Location | 625 E Nicollet Blvd, Burnsville, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013026053 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223E0200X | Dentist - Endodontics | 10388 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew Mark Doroschak, DDS, MS 625 E Nicollet Blvd, Suite 340, Burnsville, MN 55337-6734 Ph: (952) 435-0370 | Dr Andrew Mark Doroschak, DDS, MS 625 E Nicollet Blvd, Suite 340, Burnsville, MN 55337-6734 Ph: (952) 435-0370 |
News Archive
As student athletes prepare to return to school, it's crucial they wear protective gear, like mouthguards, even when playing sports not usually associated with contact. A properly fitted mouthguard can help save your child's smile and keep them off the injured list.
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced that they will move forward with a Phase 3 clinical trial of ARQ 197, a small molecule inhibitor of the c-Met receptor tyrosine kinase, in patients with non-small cell lung cancer (NSCLC). In connection with this decision, the sponsor company, Daiichi Sankyo, will file a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) for a trial comparing ARQ 197 plus erlotinib against erlotinib plus placebo.
Cyberonics, Inc. announced today that Vagus Nerve Stimulation (VNS) Therapy, the only FDA-approved implantable medical device for the treatment of refractory epilepsy, will be featured in 14 presentations at the American Epilepsy Society's (AES) Annual Meeting, taking place December 4-8 at the Hynes Convention Center in Boston, Massachusetts.
Tenaxis Medical, Inc., (www.tenaxismedical.com), a medical device company focused on the development of functionally designed surgical sealants has received approval from its EU Notified Body, BSI, to expand its CE Mark indications for ArterX Surgical Sealant.
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, today announced that it received approval for its AUTOMAGLIA 90 fully-automated ECLIA analyzer as well as Down Syndrome screening kit from the State Food and Drug Administration of China.
› Verified 6 days ago
Dr. James Nasby, DDS MSD Dentist Medicare: Not Enrolled in Medicare Practice Location: 14344 Burnhaven Dr, Burnsville, MN 55337 Phone: 952-435-6213 | |
Dr. Jerald Herman Lyng, D.D.S., M.S. Dentist Medicare: Medicare Enrolled Practice Location: 625 E Nicollet Blvd, Suite 340, Burnsville, MN 55337 Phone: 952-435-0370 | |
Dr. Timothy John Ake, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 12401 Nicollet Ave, Burnsville, MN 55337 Phone: 952-890-4255 | |
Dr. Tiffany T Waki, D.D.S., M.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 14000 Nicollet Ave, Suite 300, Burnsville, MN 55337 Phone: 952-892-3282 | |
Luke Veenstra, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 351 Nicollet Blvd W, Burnsville, MN 55337 Phone: 952-435-4142 | |
Mrs. Sara Rohrer Tuchscherer, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 14321 Nicollet Court, Suite 200, Burnsville, MN 55306 Phone: 952-892-3808 Fax: 952-892-7727 |